Log in to your Inderes Free account to see all free content on this page.
Scandinavian ChemoTech
3.75 SEK
+7.14 %
Less than 1K followers
CMOTEC B
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+7.14 %
-1.32 %
-25.30 %
+2.46 %
+21.36 %
+204.88 %
-52.35 %
-64.36 %
-90.04 %
Scandinavian ChemoTech is a Swedish company that develops and markets medical technology based on electrochemotherapy for the treatment of cancer. The company offers systems and solutions to clinics in oncology and veterinary medicine and has operations in international markets, including India and Southeast Asia. The company was founded in 2015 and is headquartered in Lund, Sweden.
Read moreMarket cap
95.45M SEK
Turnover
46.88K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
28.4.
2026
Interim report Q1'26
5.5.
2026
General meeting '26
11.8.
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
ChemoTech: (RETRANS) Clinical Study on TSE in Equine Sarcoid Mgmt. to be presented at the upcoming ECVS Meeting.
ChemoTech: Clinical Study on TSE in Equine Sarcoid Management to be presented at the upcoming ECVS Meeting
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio